Lixte Biotechnology Inc. (LIXT)
NASDAQ: LIXT
· Real-Time Price · USD
3.56
-0.34 (-8.72%)
At close: Aug 15, 2025, 3:59 PM
3.62
1.69%
After-hours: Aug 15, 2025, 05:16 PM EDT
Lixte Biotechnology Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.09M | -3.32M | -3.59M | -4M | -4.03M | -4.69M | -5.09M | -5.69M | -6.15M | -6.02M | -6.31M | -6.71M | -6.47M | -6.66M | -6.73M | -5.61M | -5.97M | -4.61M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 177.72K | 308.41K | 311.6K | 337.68K | 449.78K | 599.15K | 773.2K | 1.05M | 1.34M | 1.48M | 1.55M | 1.91M | 1.86M | 2.28M | 2.6M | 2.04M | 2.76M | 1.91M |
Other Working Capital | -12.83K | 123.12K | 127.8K | 278.21K | 364.79K | 258.33K | 94.54K | 118.18K | -163.68K | -349.97K | -36.79K | -24.56K | 113.3K | 70.08K | 17.66K | -203.16K | -253.56K | -75.6K |
Other Non-Cash Items | 436.79K | 168.79K | 168.79K | 168.79K | n/a | 137.16K | 420.28K | 883.3K | 1.35M | 1.21M | 1.12M | 1.39M | 1.22M | 2.06M | 2.56M | 1.83M | 1.53M | 697.43K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -137.79K | -96.79K | -58.96K | 26.07K | 128.7K | 280.42K | 20.56K | 31.95K | -23.12K | -308.08K | 154.76K | 254.94K | 311.37K | 223.93K | -13.44K | -169.81K | -220.21K | -42.25K |
Operating Cash Flow | -2.61M | -2.94M | -3.16M | -3.47M | -3.45M | -3.81M | -4.29M | -4.6M | -4.83M | -4.85M | -4.61M | -4.55M | -4.3M | -4.15M | -4.14M | -3.74M | -3.43M | -2.74M |
Capital Expenditures | 8.00 | 3.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.14M | n/a | n/a | n/a | 5.14M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 914.23K | 914.23K | n/a | 3.14M | 3.14M | 3.14M | 3.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 914.23K | 914.23K | n/a | 3.14M | 3.14M | 3.14M | 3.14M | -5.14M | n/a | n/a | n/a | 5.14M | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | 41.00 | 41.00 | 6.32K | 5.15M | 10.29M | 10.3M | 10.28M | 5.15M | 100K | 190.09K | 207.63K | 4.93M | 4.77M | 4.61M |
Financial Cash Flow | 904.23K | 914.23K | n/a | n/a | 3.14M | 3.14M | 3.14M | 8.28M | 10.29M | 15.44M | 15.42M | 10.29M | 5.24M | 190.09K | 3.9M | 8.62M | 8.46M | 8.3M |
Net Cash Flow | -1.71M | -2.03M | -3.16M | -3.47M | -317.7K | -674.04K | -1.15M | -1.46M | -4.82M | 310.56K | 529.65K | 601.25K | 937.29K | -3.96M | -245.52K | 4.88M | 5.02M | 5.55M |
Free Cash Flow | -2.61M | -2.94M | -3.16M | -3.47M | -3.45M | -3.81M | -4.29M | -4.6M | -4.83M | -4.85M | -4.61M | -4.55M | -4.3M | -4.15M | -4.14M | -3.74M | -3.43M | -2.74M |